Heron Therapeutics (HRTX) Prepaid Assets (2010 - 2026)
Heron Therapeutics (HRTX) reported Prepaid Assets of $8.0 million for Q1 2026, down 69.93% on a YoY basis from $26.5 million in Q1 2025, and down 12.46% quarter-over-quarter from $9.1 million in Q4 2025.
Heron Therapeutics (HRTX) Prepaid Assets (2010 - 2026) Analysis & Trends
Heron Therapeutics has reported Prepaid Assets for 17 years, with the latest figure at $8.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 69.93% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (down 69.93% YoY), and the FY2025 full-year result was $9.1 million, down 48.55% from the prior year.
- Prepaid Assets for Q1 2026 stood at $8.0 million, down from $9.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $26.5 million in Q1 2025, with the low at $6.1 million in Q4 2023.
- Historically, Prepaid Assets has averaged $12.5 million across 5 years, with a median of $10.8 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets plunged 72.4% — and 2025, when it soared 302.4%.
- Heron Therapeutics' Prepaid Assets stood at $14.0 million in 2022, then slumped by 56.18% to $6.1 million in 2023, then surged by 189.15% to $17.7 million in 2024, then sank by 48.55% to $9.1 million in 2025, then fell by 12.46% to $8.0 million in 2026.
- The last three Prepaid Assets figures came in at $8.0 million (Q1 2026), $9.1 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.97 Mn |
| Dec 31, 2025 | 9.10 Mn |
| Sep 30, 2025 | 22.84 Mn |
| Jun 30, 2025 | 17.39 Mn |
| Mar 31, 2025 | 26.49 Mn |
| Dec 31, 2024 | 17.69 Mn |
| Sep 30, 2024 | 11.31 Mn |
| Jun 30, 2024 | 7.25 Mn |
| Mar 31, 2024 | 6.58 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 10.77 Mn |
| Jun 30, 2023 | 10.72 Mn |
| Mar 31, 2023 | 14.63 Mn |
| Dec 31, 2022 | 13.96 Mn |
| Sep 30, 2022 | 7.63 Mn |
| Jun 30, 2022 | 9.05 Mn |
| Mar 31, 2022 | 13.11 Mn |
| Dec 31, 2021 | 12.96 Mn |
| Sep 30, 2021 | 27.64 Mn |
| Jun 30, 2021 | 23.73 Mn |